Euro-BioImaging welcomes IVIM Technology to the Industry Board


Published January 8, 2025
Category

Euro-BioImaging is delighted to announce that IVIM Technology has joined the Euro-BioImaging Industry Board (EBIB) effective 1st January 2025. The company will be represented by their CMO and Head of Sales, Sujin Park.

Sujin Park, CMO

IVIM Technology's membership further strengthens the collaboration between imaging companies and researchers in our network, particularly benefiting Nodes working with pre-clinical imaging. As a pioneer in intravital microscopy, IVIM Technology offers advanced live animal imaging solutions and training to the scientific community.

Their addition to the Industry Board diversifies the industry expertise accessible to the Euro-BioImaging community. By welcoming a second company specializing in pre-clinical imaging, we aim to stimulate exchange within the biomedical research community, potentially fostering new collaborations and innovative ways of knowledge sharing.

IVIM Technology will present at our Tech Exchange webinar on 7th February 2025.

Euro-BioImaging looks forward to a fruitful collaboration with IVIM Technology.

contributed by Claudia Pfander


More news from Euro-BioImaging

Group photo at the EU-Australian Health Research Infrastructure Symposium in Prato, 2025.

September 24, 2025

Successful Australian & European Health Research Infrastructures symposium

From September 16-19, 2025, representatives of European and Australian Health Research Infrastructures gathered at the Monash University Prato Centre in Prato, Italy. The Euro-BioImaging…

September 23, 2025

New European strategy on Research & Technology Infrastructures

The European Commission has published its new Strategy on Research & Technology Infrastructures that aims to “make the EU the best place in the…

Representative MRI images of livers.

September 16, 2025

Spotlight - Johnson Lok – Advanced Microbiome Therapeutics (AMT)

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent liver disease globally, yet no therapies…